Volume 60, Issue 5, Pages 908-916 (November 2011) Late Gastrointestinal Toxicities Following Radiation Therapy for Prostate Cancer  Sung Kim, Shunhua Shen, Dirk F. Moore, Weichung Shih, Yong Lin, Hui Li, Matthew Dolan, Yu-Hsuan Shao, Grace L. Lu-Yao  European Urology  Volume 60, Issue 5, Pages 908-916 (November 2011) DOI: 10.1016/j.eururo.2011.05.052 Copyright © 2011 Terms and Conditions

Fig. 1 Cumulative incidence estimates of any gastrointestinal (GI) toxicity by treatment group. Competing risk was computed by using cumulative incidence adjusting for death from any cause prior to any GI toxicity. European Urology 2011 60, 908-916DOI: (10.1016/j.eururo.2011.05.052) Copyright © 2011 Terms and Conditions

Fig. 2 Cumulative incidence estimates of any gastrointestinal (GI) toxicity by radiation modality. Competing risk was computed by using cumulative incidence adjusting for death from any cause prior to any GI toxicity. 3D CRT=three-dimensional conformal radiotherapy; Brachy=brachytherapy; IMRT=intensity-modulated radiotherapy; Proton=proton beam therapy. European Urology 2011 60, 908-916DOI: (10.1016/j.eururo.2011.05.052) Copyright © 2011 Terms and Conditions

Fig. 3 (a) Cumulative incidence estimates of any gastrointestinal (GI) toxicity by year of cancer diagnosis for proton-treated patients. Competing risk was computed by using cumulative incidence adjusting for death from any causes prior to any GI toxicity. (b) Cumulative incidence estimates of any GI toxicity by year of cancer diagnosis for patients treated with intensity-modulated radiotherapy. Competing risk was computed by using cumulative incidence adjusting for death from any causes before any GI toxicity. European Urology 2011 60, 908-916DOI: (10.1016/j.eururo.2011.05.052) Copyright © 2011 Terms and Conditions